{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:28Z","timestamp":1786985428019,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmcl.2021.128013","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T06:41:58Z","timestamp":1617259318000},"page":"128013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans"],"prefix":"10.1016","volume":"41","author":[{"given":"Mostafa","family":"Teymuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2562-965X","authenticated-orcid":false,"given":"Masoomeh","family":"Shams-Ghahfarokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Razzaghi-Abyaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128013_b0005","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.bpj.2016.08.032","article-title":"Mode of action of a designed antimicrobial peptide: high potency against Cryptococcus neoformans","volume":"111","author":"Datta","year":"2016","journal-title":"Biophys J"},{"key":"10.1016\/j.bmcl.2021.128013_b0010","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4155\/fmc-2016-0053","article-title":"Sphingolipids as targets for treatment of fungal infections","volume":"8","author":"Rollin-Pinheiro","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2021.128013_b0015","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/0040-4020(96)00132-9","article-title":"Total synthesis of an antifungal cyclic depsipeptide aureobasidin A","volume":"52","author":"Kurome","year":"1996","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2021.128013_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.43.1.1","article-title":"Antifungal peptides: novel therapeutic compounds against emerging pathogens","volume":"43","author":"De Lucca","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.128013_b0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/EC.00103-15","article-title":"Virulence-associated enzymes of Cryptococcus neoformans","volume":"14","author":"Almeida","year":"2015","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bmcl.2021.128013_b0030","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/EC.00458-07","article-title":"Beta 1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids","volume":"7","author":"Castle","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bmcl.2021.128013_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/foy119","article-title":"Pharmacological inhibition of pigmentation in Cryptococcus","volume":"19","author":"Zimbres","year":"2019","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.bmcl.2021.128013_b0040","first-page":"6","article-title":"Clinical and laboratory standards institute: reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard","volume":"3","author":"Wayne","year":"2008","journal-title":"CLSI Document M27\u2013A3 and Supplement S."},{"key":"10.1016\/j.bmcl.2021.128013_b0045","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-: Approved Standard CLSI Document M27-A3","author":"CLSI. Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.bmcl.2021.128013_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11046-010-9358-6","article-title":"Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis","volume":"171","author":"Sun","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bmcl.2021.128013_b0055","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1128\/JCM.37.10.3332-3337.1999","article-title":"Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans","volume":"37","author":"Arthington-Skaggs","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bmcl.2021.128013_b0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2191-0855-3-54","article-title":"Phenyl aldehyde and propanoids exert multiple sites of action towards cell membrane and cell wall targeting ergosterol in Candida albicans","volume":"3","author":"Khan","year":"2013","journal-title":"AMP Exp"},{"key":"10.1016\/j.bmcl.2021.128013_b0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ja.2006.39","article-title":"Relationship between cell morphology and intracellular potassium concentration in Candida albicans","volume":"59","author":"Watanabe","year":"2006","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2021.128013_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.00798","article-title":"Role of Cln1 during melanization of Cryptococcus neoformans","volume":"6","author":"Garc\u00eda-Rodas","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2021.128013_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/EC.00235-12","article-title":"Cryptococcus neoformans phosphoinositide-dependent kinase 1 (PDK1) ortholog is required for stress tolerance and survival in murine phagocytes","volume":"12","author":"Chabrier-Rosell\u00f3","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bmcl.2021.128013_b0080","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00436-018-5992-6","article-title":"Effect of oxidative stress on vital indicators of Acanthamoeba castellanii (T4 genotype)","volume":"117","author":"Motavalli","year":"2018","journal-title":"Parasitol Res"},{"key":"10.1016\/j.bmcl.2021.128013_b0085","first-page":"89","article-title":"Biological activities of a new antimicrobial peptide from Coriandrum sativum","volume":"4","author":"Zare-Shehneh","year":"2014","journal-title":"Int J Biosci"},{"key":"10.1016\/j.bmcl.2021.128013_b0090","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3892\/etm.2015.2838","article-title":"Antiproliferative effect and characterization of a novel antifungal peptide derived from human chromogranin A","volume":"10","author":"Li","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmcl.2021.128013_b0095","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.febslet.2010.06.005","article-title":"Bacillus subtilis SSE4 produces subtulene A, a new lipopeptide antibiotic possessing an unusual C15 unsaturated \u03b2-amino acid","volume":"584","author":"Thasana","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmcl.2021.128013_b0100","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s11274-015-1857-7","article-title":"Inhibitory effect of eugenol on aflatoxin B1 production in Aspergillus parasiticus by downregulating the expression of major genes in the toxin biosynthetic pathway","volume":"31","author":"Jahanshiri","year":"2015","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.bmcl.2021.128013_b0105","first-page":"9","article-title":"Antifungal activity of eugenol on Cryptococcus neoformans biological activity and Cxt1p gene expression","volume":"6","author":"Hassanpour","year":"2020","journal-title":"Curr Med Mycol"},{"key":"10.1016\/j.bmcl.2021.128013_b0110","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01290-18","article-title":"Cryptococcus neoformans, unlike Candida albicans, forms aneuploid clones directly from uninucleated cells under fluconazole stress","volume":"9","author":"Chang","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.bmcl.2021.128013_b0115","series-title":"Hope on the Horizon: Novel Fungal Treatments in Development","author":"Rauseo","year":"2020"},{"key":"10.1016\/j.bmcl.2021.128013_b0120","first-page":"253","article-title":"Sphingolipids with inositolphosphate-containing head groups","volume":"26","author":"Lester","year":"1993","journal-title":"Adv Lipid Res"},{"key":"10.1016\/j.bmcl.2021.128013_b0125","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/AAC.49.5.1794-1801.2005","article-title":"Inhibitory effect of aureobasidin A on Toxoplasma gondii","volume":"49","author":"Sonda","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.128013_b0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.riam.2017.07.001","article-title":"A study on Candida biofilm growth characteristics and its susceptibility to aureobasidin A","volume":"35","author":"Munusamy","year":"2018","journal-title":"Rev Iberoam de Micol"},{"key":"10.1016\/j.bmcl.2021.128013_b0135","first-page":"fnx255","article-title":"Overexpression of PDR16 confers resistance to complex sphingolipid biosynthesis inhibitor aureobasidin A in yeast Saccharomyces cerevisiae","volume":"365","author":"Katsuki","year":"2017","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmcl.2021.128013_b0140","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14787210.2020.1792288","article-title":"Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies","volume":"18","author":"Mota Fernandes","year":"2020","journal-title":"Exp Rev Anti-infect Ther"},{"key":"10.1016\/j.bmcl.2021.128013_b0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jac\/dkl518","article-title":"Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A","volume":"59","author":"Tanaka","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2021.128013_b0150","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","article-title":"Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic","volume":"46","author":"Takesako","year":"1993","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2021.128013_b0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1568005043340597","article-title":"IPC synthase as a useful target for antifungal drugs","volume":"4","author":"Sugimoto","year":"2004","journal-title":"Curr Drug Targets-Infect Disord"},{"key":"10.1016\/j.bmcl.2021.128013_b0160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/AAC.44.3.651-653.2000","article-title":"Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species","volume":"44","author":"Zhong","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.128013_b0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fmicb.2012.00133","article-title":"Dysregulation of ion homeostasis by antifungal agents","volume":"3","author":"Zhang","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2021.128013_b0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4161\/viru.2.4.16136","article-title":"The effect of L-DOPA on Cryptococcus neoformans growth and gene expression","volume":"2","author":"Eisenman","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.bmcl.2021.128013_b0175","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1128\/jb.175.21.7102-7104.1993","article-title":"Antioxidant function of fungal melanin","volume":"175","author":"Jacobson","year":"1993","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bmcl.2021.128013_b0180","first-page":"171","article-title":"Erratum: Melanization affects susceptibility of Cryptococcus neoformans to heat and cold (FEMS Microbiol. Lett.(1997) 153 (265-272) PII: S0378109797002395)","volume":"156","author":"Rosas","year":"1997","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmcl.2021.128013_b0185","doi-asserted-by":"crossref","first-page":"32709","DOI":"10.1074\/jbc.272.51.32709","article-title":"Khafrefungin, a novel inhibitor of sphingolipid synthesis","volume":"272","author":"Mandala","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.128013_b0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.41.3.672","article-title":"Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae","volume":"41","author":"Endo","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.128013_b0195","doi-asserted-by":"crossref","first-page":"14327","DOI":"10.1074\/jbc.M708927200","article-title":"Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides","volume":"283","author":"Klutts","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.128013_b0200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/EC.4.1.202-208.2005","article-title":"Distinct stress responses of two functional laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant Tsa1","volume":"4","author":"Missall","year":"2005","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bmcl.2021.128013_b0205","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760180391","article-title":"Drug development for cryptococcosis treatment: what can patents tell us?","volume":"114","author":"Santos-Gandelman","year":"2019","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.bmcl.2021.128013_b0210","doi-asserted-by":"crossref","first-page":"170334","DOI":"10.1016\/j.peptides.2020.170334","article-title":"Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis","volume":"130","author":"Ma","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.bmcl.2021.128013_b0215","doi-asserted-by":"crossref","first-page":"126713","DOI":"10.1016\/j.bmcl.2019.126713","article-title":"Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp","volume":"29","author":"Trzoss","year":"2019","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21002390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21002390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:42:57Z","timestamp":1760773377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":43,"alternative-id":["S0960894X21002390"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128013","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128013"}}